Inflammatory Arthritis Clinical Trial
Official title:
Examining the Effects of Person-centered Lifestyle Intervention in Individuals With Rheumatoid Arthritis: a Randomized Controlled Trial
It is aimed to examine the effects of person-centered lifestyle intervention on occupational performance, general health status, and quality of life in individuals with rheumatoid arthritis.
Status | Recruiting |
Enrollment | 40 |
Est. completion date | March 30, 2024 |
Est. primary completion date | October 23, 2023 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 65 Years |
Eligibility | Inclusion Criteria: - Being diagnosed with RA between the ages of 18-65 and meeting the ACR/EULAR diagnostic criteria - Patients with low to moderate disease activity (DAS28 =5.1) - No pharmacological treatment changes for RA in the last 3 months - Have not had any surgery in the last 6 months - Understand and cooperate with testing guidelines - to be literate Exclusion Criteria: - Having any musculoskeletal disease, neurological disease, and/or visual and auditory impairment other than RA - Pregnancy |
Country | Name | City | State |
---|---|---|---|
Turkey | Manisa Celal Bayar University Hafsa Sultan Hospital | Mani?sa |
Lead Sponsor | Collaborator |
---|---|
Hacettepe University |
Turkey,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Canadian Occupational Performance Measurement | COPM is a standardized measurement tool that reflects the change in an individual's personal perception of activity performance and satisfaction over a period of time. It is designed to identify the activity performance problems of the individual, to give priority to these areas and to develop person-centered practice. In this assessment scale, activity performance problems faced by the person in the areas of self-care, productivity, play-free time are recorded with a semi-structured interview method. Among these areas, the person is asked to select 5 problems that he prioritizes and to rate each problem area between 1 and 10 points. A higher score on this rating indicates greater performance and satisfaction. The calculation is made by dividing the total performance and satisfaction score by the number of selected activities. | change from baseline score at the end of 4 weeks and 6 months | |
Secondary | The DAS 28 Disease Activity scale | Disease Activity Score (DAS-28), which includes 28 joints, is used to monitor objective and subjective measures of disease activity in individuals with RA [33, 34]. The DAS-28 has been shown to have good validity and internal consistency reliability for monitoring this patient population [35] and is able to distinguish between patients with high and low disease activity [33]. Objective measures for rheumatoid arthritis are the number of swollen joints and the level of inflammation (erythrocyte sedimentation rate or C-reactive protein); subjective measures are the number of tender joints and the patient's overall health assessment. Disease activity scores range from 0 (not completely active) to 9.4 (very active). It is classified as = 3.2 = mild, >3.2 to =5.1 = moderate, and >5.1 = severe [36]. | change from baseline score at the end of 4 weeks and 6 months | |
Secondary | Health Assessment Questionnaire (HAQ) | Evaluate how an individual's health status affects their physical function. It consists of eight subsections containing 20 activities (dressing and preparation, sitting-standing, eating, walking, hygiene, reaching, grip strength, and other activities) and each subsection contains two or three questions. All questions are rated on a four-point likert (0=I can do it easily), and (3=I can't do it at all). Eight subdivision scores are added up and divided by eight. A high score indicates poor health [37]. The Turkish validity and reliability of the test was established [38]. | change from baseline score at the end of 4 weeks and 6 months | |
Secondary | Hospital Anxiety and Depression Scale (HADS) | The hospital anxiety and depression scale was developed by Zigmond and Snaith in 1983 [39]. In our country, the validity and reliability study was carried out by Aydemir[15] in 1997 [40]. The scale is used to determine the risk of anxiety and depression in the patient, to measure its level and change in severity. | change from baseline score at the end of 4 weeks and 6 months | |
Secondary | General Self-Efficacy Scale | The General Self-Efficacy Scale - Turkish form is a valid and reliable tool for measuring the general self-efficacy of people aged 18 years and older who are at least primary school graduates. The scale consists of 17 items and a 5-point likert structure. Bandura argues that the perception of self-efficacy is one of the main determinants of human behavior and behavioral changes [43]. The use of the concept of self-efficacy in the formation and change of patients' health-related behaviors seems to be beneficial in the field of health. The Turkish validity and reliability study of the scale was carried out by Yildirim and Ilhan in 2010 [44]. | change from baseline score at the end of 4 weeks and 6 months | |
Secondary | Rheumatoid Arthritis Quality of Life Scale | It is a disease-specific scale developed for patients with Rheumatoid arthritis and evaluates the quality of life multi-dimensionally. It consists of 30 questions prepared to be answered as yes/no. Scores range from 0 to 30, and high scores indicate poor quality of life [45]. The Turkish version of the RAQoL was used in this study [46]. | change from baseline score at the end of 4 weeks and 6 months | |
Secondary | The Bristol Rheumatoid Arthritis Fatigue Multidimensional Questionnaire (BRAF-MDQ) | It was developed to evaluate the effect of fatigue in different dimensions in RA patients. In the questionnaire, 4 questions (questions 1-4) evaluate physical fatigue, 7 questions evaluate fatigue in activities of daily living (ADL), 5 questions evaluate cognitive fatigue (questions 12-16), and 4 evaluate emotional fatigue. There are 20 questions in total (questions 17-20). All questions except the first 3 questions are asked to be answered according to the 4-point Likert system (none, a little, a lot, and a lot). The questionnaire completed by the patient evaluates the last seven days. The patient can leave a total of 3 questions blank. But it should answer questions 1 and 2. The patient scores between 0-70. A high score indicates high fatigue [41]. A Turkish validity and reliability study was conducted [42]. | change from baseline score at the end of 4 weeks and 6 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT04249817 -
Keeping Stable Inflammatory Arthritis Patients in Their Communities With the Advanced Clinician Practitioner in Arthritis Care
|
N/A | |
Not yet recruiting |
NCT06162195 -
The ACTIVE Trial: A Prospective Randomised Control Trial Of The H1 Implant Versus Total Hip Replacement
|
N/A | |
Completed |
NCT01303874 -
Etanercept and Methotrexate in Patients to Induce Remission in Early Arthritis (EMPIRE)
|
Phase 4 | |
Active, not recruiting |
NCT03343171 -
Continuum Ceramic on Ceramic Bearing Post Market Clinical Follow-Up Study
|
||
Recruiting |
NCT04426747 -
Impact of Barriers and Facilitators to Physical Activity in Patients With Inflammatory Arthritis
|
||
Active, not recruiting |
NCT04956380 -
Self-assessment Triage in Inflammatory Arthritis
|
N/A | |
Active, not recruiting |
NCT02538757 -
Safety and Effectiveness Study of the Live Zoster Vaccine in Anti-Tumor Necrosis Factor (TNF) Users (VERVE)
|
Phase 2 | |
Completed |
NCT01874067 -
C-GLOVES: the Effectiveness of Compression Gloves in Arthritis
|
||
Completed |
NCT03140995 -
Sleep and Exercise in Rheumatoid Arthritis
|
N/A | |
Withdrawn |
NCT02027298 -
Abatacept for Patients With Inflammatory Arthritis Associated With Sjögren's Syndrome: an Open-Label Phase II Study
|
Phase 2 | |
Recruiting |
NCT00512239 -
Prognostic Evaluation of Inflammatory Polyarthritis of Recent Onset
|
||
Terminated |
NCT03937856 -
Smartphone Mindfulness Meditation for Patients With Rheumatic Diseases
|
N/A | |
Completed |
NCT02436785 -
Do Inflammatory Arthritis Inpatients Receiving Group Music Therapy Improve Pain Compared to Music Listening?
|
N/A | |
Completed |
NCT02538341 -
Safety and Effectiveness of Live Zoster Vaccine in Anti-Tumor Necrosis Factor (TNF) Users (VERVE Trial)
|
Phase 2 | |
Completed |
NCT02465879 -
Allied Health in Rheumatology Triage Project
|
N/A | |
Completed |
NCT03672916 -
Allofit® IT Ceramic Bearing System in Total Hip Arthroplasty
|
||
Completed |
NCT04806867 -
Selection of Patients With Chronic Inflammatory Rheumatism Requiring Management During the COVID-19 Pandemia
|
||
Active, not recruiting |
NCT01307384 -
Zimmer Continuum Metal on Polyethylene (MoP) PostMarket Clinical Followup (PMCF) Study
|
||
Terminated |
NCT03672370 -
PMCF Study on the Safety and Performance of the Alloclassic Variall Cup Ceramic Bearing System in Total Hip Arthroplasty
|
||
Not yet recruiting |
NCT05216757 -
Efficacy and Safety of Iguratimod in Patients With Hand Osteoarthritis (ESIGO)
|
Phase 2/Phase 3 |